ON THIS PAGE: You will find information about how many men learn they have this type of cancer each year and some general survival information. Remember, survival rates depend on several factors. To see other pages, use the menu on the side of your screen.
This year, an estimated 1,640 men in the United States will be diagnosed with penile cancer and about 320 men will die from the disease. Penile cancer is rare in the United States and makes up less than 1% of all cancer diagnosed in men. It is more common in some parts of Asia, Africa, and South America, where it accounts for up to 10% of cancers in men.
The five-year survival rate is the percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases. The five-year survival rate of men with penile cancer that has not spread when it is first diagnosed is about 85%. If the cancer has spread near the penis, called local spread, the five-year survival rate is 59%. If the cancer has spread to other parts of the body, called distant spread, the five-year survival rate is 11%.
Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of men with this type of cancer, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he will live with penile cancer. Because the survival statistics are measured in five-year intervals, they may not represent recent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics.
Statistics adapted from the American Cancer Society's publication, Cancer Facts and Figures 2014.
To continue reading this guide, use the menu on the side of your screen to select another section.